-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Mirati Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2022.
- Mirati Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $44.6M, a 3.63% increase year-over-year.
- Mirati Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $193M, a 21.5% increase year-over-year.
- Mirati Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $186M, a 64% increase from 2021.
- Mirati Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $114M, a 32.2% increase from 2020.
- Mirati Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $85.8M, a 54.6% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)